TERMIS EU – Rhodes, Greece – 27-31 May 2019

Marco Thio and Matei Cirstea will attend TERMIS: Tissue Engineering Therapies: From Concept to Clinical Translation & Commercialisation in Rhodes from 27th to 31st May. Marco will be presenting on the industrial perspective of electospinning as a method fr biomaterial manufacture. TERMIS is the most prominent organisation in the field of tissue engineering and regenerative… Read more »

Biomaterials Risk Management BIORIMA H2020 grant

The Electrospinning Company is a partner in the EU funded H2020 Research and Innovation action BIORIMA (Biomaterial Risk Management). The project aims to develop an integrated risk management framework for nano-biomaterials used in advanced therapeutic medicinal products and medical devices. The BIORIMA risk management framework is a structure upon which the validated tools and methods… Read more »